Annual SG&A
$14.77 B
+$1.09 B+8.00%
31 December 2023
Summary:
Pfizer annual selling, general & administrative expenses is currently $14.77 billion, with the most recent change of +$1.09 billion (+8.00%) on 31 December 2023. During the last 3 years, it has risen by +$3.17 billion (+27.37%). PFE annual SG&A is now -22.15% below its all-time high of $18.97 billion, reached on 31 December 2010.PFE Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.24 B
-$473.00 M-12.73%
30 September 2024
Summary:
Pfizer quarterly selling, general & administrative expenses is currently $3.24 billion, with the most recent change of -$473.00 million (-12.73%) on 30 September 2024. Over the past year, it has dropped by -$37.00 million (-1.13%). PFE quarterly SG&A is now -42.83% below its all-time high of $5.67 billion, reached on 31 December 1998.PFE Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$477.33 B
-$5.35 B-1.11%
30 September 2024
Summary:
Pfizer TTM selling, general & administrative expenses is currently $477.33 billion, with the most recent change of -$5.35 billion (-1.11%) on 30 September 2024. Over the past year, it has increased by +$462.49 billion (+3116.27%). PFE TTM SG&A is now -6.77% below its all-time high of $19.14 billion, reached on 01 September 2010.PFE TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PFE Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +8.0% | -1.1% | +3116.3% |
| 3 y3 years | +27.4% | +11.9% | +3768.8% |
| 5 y5 years | +17.1% | -0.5% | +3788.9% |
PFE Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.4% | -30.2% | +25.1% | -6.8% | +24.3% |
| 5 y | 5 years | at high | +27.4% | -30.2% | +27.7% | -6.8% | +26.4% |
| alltime | all time | -22.1% | +886.6% | -42.8% | +817.7% | -6.8% | >+9999.0% |
Pfizer Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.24 B(-12.7%) | $15.03 B(-0.2%) |
| June 2024 | - | $3.72 B(+6.4%) | $15.07 B(+1.5%) |
| Mar 2024 | - | $3.50 B(-23.6%) | $14.85 B(+0.5%) |
| Dec 2023 | $14.77 B(+8.0%) | $4.58 B(+39.4%) | $14.77 B(-0.5%) |
| Sept 2023 | - | $3.28 B(-6.2%) | $14.84 B(-0.7%) |
| June 2023 | - | $3.50 B(+2.3%) | $14.95 B(+3.1%) |
| Mar 2023 | - | $3.42 B(-26.4%) | $14.50 B(+6.0%) |
| Dec 2022 | $13.68 B(+7.7%) | $4.64 B(+37.0%) | $13.68 B(+4.1%) |
| Sept 2022 | - | $3.39 B(+11.3%) | $13.14 B(+3.9%) |
| June 2022 | - | $3.05 B(+17.5%) | $12.64 B(+1.0%) |
| Mar 2022 | - | $2.59 B(-36.8%) | $12.52 B(-1.4%) |
| Dec 2021 | $12.70 B(+9.5%) | $4.10 B(+41.6%) | $12.70 B(+3.0%) |
| Sept 2021 | - | $2.90 B(-0.8%) | $12.34 B(+2.0%) |
| June 2021 | - | $2.92 B(+5.3%) | $12.10 B(+2.2%) |
| Mar 2021 | - | $2.78 B(-25.7%) | $11.83 B(+2.0%) |
| Dec 2020 | $11.60 B(-8.9%) | $3.74 B(+40.7%) | $11.60 B(+10.7%) |
| Sept 2020 | - | $2.66 B(-0.0%) | $10.47 B(-5.4%) |
| June 2020 | - | $2.66 B(+4.6%) | $11.08 B(-7.1%) |
| Mar 2020 | - | $2.54 B(-2.9%) | $11.93 B(-6.3%) |
| Dec 2019 | $12.73 B(+0.9%) | $2.62 B(-19.8%) | $12.73 B(+3.7%) |
| Sept 2019 | - | $3.26 B(-7.1%) | $12.27 B(-1.9%) |
| June 2019 | - | $3.51 B(+5.2%) | $12.51 B(-0.2%) |
| Mar 2019 | - | $3.34 B(+54.3%) | $12.54 B(-0.6%) |
| Dec 2018 | $12.61 B(-14.8%) | $2.16 B(-38.1%) | $12.61 B(-15.9%) |
| Sept 2018 | - | $3.49 B(-1.4%) | $15.00 B(-0.1%) |
| June 2018 | - | $3.54 B(+3.8%) | $15.01 B(+0.8%) |
| Mar 2018 | - | $3.41 B(-25.1%) | $14.90 B(+0.7%) |
| Dec 2017 | $14.80 B(-0.3%) | $4.55 B(+30.0%) | $14.80 B(+0.9%) |
| Sept 2017 | - | $3.50 B(+2.2%) | $14.68 B(-0.4%) |
| June 2017 | - | $3.43 B(+3.5%) | $14.73 B(-0.3%) |
| Mar 2017 | - | $3.31 B(-25.2%) | $14.78 B(-0.5%) |
| Dec 2016 | $14.84 B(+0.2%) | $4.43 B(+24.5%) | $14.85 B(-4.0%) |
| Sept 2016 | - | $3.56 B(+2.5%) | $15.46 B(+1.9%) |
| June 2016 | - | $3.47 B(+2.5%) | $15.17 B(+0.6%) |
| Mar 2016 | - | $3.38 B(-32.9%) | $15.09 B(+1.9%) |
| Dec 2015 | $14.81 B(+5.1%) | $5.05 B(+54.4%) | $14.81 B(+7.8%) |
| Sept 2015 | - | $3.27 B(-3.4%) | $13.74 B(-2.0%) |
| June 2015 | - | $3.39 B(+9.1%) | $14.03 B(-0.9%) |
| Mar 2015 | - | $3.10 B(-22.0%) | $14.16 B(+0.5%) |
| Dec 2014 | $14.10 B(-1.8%) | $3.98 B(+12.0%) | $14.10 B(-1.2%) |
| Sept 2014 | - | $3.56 B(+1.0%) | $14.27 B(+1.1%) |
| June 2014 | - | $3.52 B(+15.8%) | $14.11 B(-0.5%) |
| Mar 2014 | - | $3.04 B(-26.8%) | $14.18 B(-1.2%) |
| Dec 2013 | $14.36 B(-5.4%) | $4.15 B(+22.3%) | $14.36 B(-1.3%) |
| Sept 2013 | - | $3.40 B(-5.5%) | $14.54 B(-0.7%) |
| June 2013 | - | $3.59 B(+11.6%) | $14.64 B(-0.5%) |
| Mar 2013 | - | $3.22 B(-25.8%) | $14.71 B(-4.9%) |
| Dec 2012 | $15.17 B(-13.7%) | $4.34 B(+24.2%) | $15.46 B(+2.6%) |
| Sept 2012 | - | $3.49 B(-4.7%) | $15.07 B(-6.0%) |
| June 2012 | - | $3.67 B(-7.6%) | $16.04 B(-6.6%) |
| Mar 2012 | - | $3.97 B(+0.6%) | $17.17 B(-3.0%) |
| Dec 2011 | $17.58 B(-7.3%) | $3.95 B(-11.5%) | $17.71 B(-6.6%) |
| Sept 2011 | - | $4.46 B(-7.1%) | $18.96 B(-0.7%) |
| June 2011 | - | $4.80 B(+6.6%) | $19.10 B(+0.1%) |
| Mar 2011 | - | $4.50 B(-13.4%) | $19.07 B(+0.5%) |
| Dec 2010 | $18.97 B(+27.5%) | $5.20 B(+13.0%) | $18.97 B(-0.9%) |
| Sept 2010 | - | $4.60 B(-3.7%) | $19.14 B(+7.4%) |
| June 2010 | - | $4.77 B(+8.4%) | $17.83 B(+8.7%) |
| Mar 2010 | - | $4.40 B(-18.0%) | $16.40 B(+10.3%) |
| Dec 2009 | $14.88 B(+2.3%) | $5.37 B(+63.5%) | $14.88 B(+13.0%) |
| Sept 2009 | - | $3.28 B(-2.0%) | $13.17 B(-1.8%) |
| June 2009 | - | $3.35 B(+16.5%) | $13.41 B(-3.7%) |
| Mar 2009 | - | $2.88 B(-21.4%) | $13.92 B(-4.2%) |
| Dec 2008 | $14.54 B(-7.0%) | $3.66 B(+3.9%) | $14.54 B(-6.4%) |
| Sept 2008 | - | $3.52 B(-8.8%) | $15.53 B(-1.6%) |
| June 2008 | - | $3.86 B(+10.6%) | $15.78 B(+0.1%) |
| Mar 2008 | - | $3.49 B(-25.0%) | $15.76 B(+0.8%) |
| Dec 2007 | $15.63 B(+0.2%) | $4.65 B(+23.5%) | $15.63 B(+0.6%) |
| Sept 2007 | - | $3.77 B(-2.0%) | $15.54 B(+0.1%) |
| June 2007 | - | $3.84 B(+14.4%) | $15.52 B(-0.2%) |
| Mar 2007 | - | $3.36 B(-26.3%) | $15.55 B(-0.2%) |
| Dec 2006 | $15.59 B | $4.56 B(+21.6%) | $15.59 B(+1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2006 | - | $3.75 B(-3.3%) | $15.38 B(+1.5%) |
| June 2006 | - | $3.88 B(+14.3%) | $15.16 B(+0.8%) |
| Mar 2006 | - | $3.40 B(-22.0%) | $15.04 B(-4.4%) |
| Dec 2005 | $15.31 B(+0.1%) | $4.36 B(+23.5%) | $15.73 B(+8.8%) |
| Sept 2005 | - | $3.53 B(-6.4%) | $14.45 B(-3.4%) |
| June 2005 | - | $3.77 B(-7.8%) | $14.96 B(-3.2%) |
| Mar 2005 | - | $4.08 B(+32.8%) | $15.46 B(+1.0%) |
| Dec 2004 | $15.30 B(+1.3%) | $3.08 B(-23.8%) | $15.30 B(-9.2%) |
| Sept 2004 | - | $4.04 B(-5.2%) | $16.86 B(+0.2%) |
| June 2004 | - | $4.26 B(+8.3%) | $16.81 B(+3.2%) |
| Mar 2004 | - | $3.93 B(-15.0%) | $16.30 B(+7.9%) |
| Dec 2003 | $15.11 B(+39.5%) | $4.63 B(+15.9%) | $15.11 B(+12.4%) |
| Sept 2003 | - | $3.99 B(+6.7%) | $13.45 B(+11.0%) |
| June 2003 | - | $3.74 B(+36.4%) | $12.11 B(+9.8%) |
| Mar 2003 | - | $2.74 B(-7.5%) | $11.03 B(+1.8%) |
| Dec 2002 | $10.83 B(+11.4%) | $2.96 B(+11.6%) | $10.83 B(+11.4%) |
| Sept 2002 | - | $2.66 B(-0.2%) | $9.72 B(+0.6%) |
| June 2002 | - | $2.66 B(+4.6%) | $9.66 B(-1.5%) |
| Mar 2002 | - | $2.54 B(+37.1%) | $9.81 B(-0.4%) |
| Dec 2001 | $9.72 B(-13.4%) | $1.86 B(-28.5%) | $9.84 B(-10.5%) |
| Sept 2001 | - | $2.60 B(-7.6%) | $11.00 B(-0.5%) |
| June 2001 | - | $2.81 B(+8.9%) | $11.06 B(-0.1%) |
| Mar 2001 | - | $2.58 B(-14.5%) | $11.07 B(-1.4%) |
| Dec 2000 | $11.22 B(+3.8%) | $3.02 B(+13.8%) | $11.22 B(+0.7%) |
| Sept 2000 | - | $2.65 B(-6.2%) | $11.15 B(+0.8%) |
| June 2000 | - | $2.82 B(+3.3%) | $11.07 B(+1.5%) |
| Mar 2000 | - | $2.73 B(-7.1%) | $10.90 B(+11.9%) |
| Dec 1999 | $10.81 B(+13.0%) | $2.94 B(+14.7%) | $9.74 B(-21.9%) |
| Sept 1999 | - | $2.57 B(-3.5%) | $12.47 B(+11.1%) |
| June 1999 | - | $2.66 B(+69.4%) | $11.23 B(+13.0%) |
| Mar 1999 | - | $1.57 B(-72.3%) | $9.93 B(+3.9%) |
| Dec 1998 | $9.56 B(+117.3%) | $5.67 B(+328.9%) | $9.56 B(+85.6%) |
| Sept 1998 | - | $1.32 B(-3.2%) | $5.15 B(+5.6%) |
| June 1998 | - | $1.37 B(+14.0%) | $4.88 B(+2.6%) |
| Mar 1998 | - | $1.20 B(-5.1%) | $4.76 B(+4.8%) |
| Dec 1997 | $4.40 B(+14.0%) | $1.26 B(+20.2%) | $4.54 B(+60.7%) |
| Sept 1997 | - | $1.05 B(-15.6%) | $2.83 B(-12.3%) |
| June 1997 | - | $1.25 B(+26.8%) | $3.22 B(-9.1%) |
| Mar 1997 | - | $982.00 M(-317.3%) | $3.54 B(-9.6%) |
| Dec 1996 | $3.86 B(-27.1%) | -$452.00 M(-131.3%) | $3.92 B(-33.3%) |
| Sept 1996 | - | $1.45 B(-7.7%) | $5.88 B(+2.3%) |
| June 1996 | - | $1.57 B(+15.1%) | $5.74 B(+4.1%) |
| Mar 1996 | - | $1.36 B(-9.5%) | $5.52 B(+2.6%) |
| Dec 1995 | $5.30 B(+20.7%) | $1.50 B(+14.6%) | $5.38 B(+4.9%) |
| Sept 1995 | - | $1.31 B(-2.3%) | $5.13 B(+4.5%) |
| June 1995 | - | $1.34 B(+10.0%) | $4.91 B(+6.1%) |
| Mar 1995 | - | $1.22 B(-2.4%) | $4.63 B(+5.4%) |
| Dec 1994 | $4.39 B(-8.4%) | $1.25 B(+14.6%) | $4.39 B(-12.2%) |
| Sept 1994 | - | $1.09 B(+2.8%) | $5.00 B(+2.1%) |
| June 1994 | - | $1.06 B(+7.8%) | $4.89 B(+6.6%) |
| Mar 1994 | - | $985.20 M(-47.0%) | $4.59 B(+0.6%) |
| Dec 1993 | $4.79 B(+27.4%) | $1.86 B(+88.2%) | $4.56 B(+21.0%) |
| Sept 1993 | - | $987.90 M(+30.3%) | $3.77 B(+2.3%) |
| June 1993 | - | $757.90 M(-20.7%) | $3.68 B(-4.3%) |
| Mar 1993 | - | $956.10 M(-10.4%) | $3.85 B(+2.4%) |
| Dec 1992 | $3.76 B(+7.6%) | $1.07 B(+18.2%) | $3.76 B(+2.5%) |
| Sept 1992 | - | $903.10 M(-2.4%) | $3.67 B(+1.3%) |
| June 1992 | - | $925.40 M(+6.8%) | $3.62 B(+1.7%) |
| Mar 1992 | - | $866.50 M(-11.2%) | $3.56 B(+2.0%) |
| Dec 1991 | $3.50 B(+13.0%) | $976.30 M(+14.1%) | $3.50 B(+1.6%) |
| Sept 1991 | - | $855.50 M(-1.2%) | $3.44 B(+3.4%) |
| June 1991 | - | $866.30 M(+8.6%) | $3.33 B(+3.5%) |
| Mar 1991 | - | $797.80 M(-13.3%) | $3.22 B(+4.0%) |
| Dec 1990 | $3.09 B(+17.1%) | $920.50 M(+24.0%) | $3.09 B(+42.4%) |
| Sept 1990 | - | $742.50 M(-1.6%) | $2.17 B(+51.9%) |
| June 1990 | - | $754.30 M(+11.7%) | $1.43 B(+111.7%) |
| Mar 1990 | - | $675.50 M | $675.50 M |
| Dec 1989 | $2.64 B(+12.2%) | - | - |
| Dec 1988 | $2.35 B(+13.0%) | - | - |
| Dec 1987 | $2.08 B(+15.9%) | - | - |
| Dec 1986 | $1.80 B(+12.3%) | - | - |
| Dec 1985 | $1.60 B(+6.8%) | - | - |
| Dec 1984 | $1.50 B | - | - |
FAQ
- What is Pfizer annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Pfizer?
- What is Pfizer annual SG&A year-on-year change?
- What is Pfizer quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Pfizer?
- What is Pfizer quarterly SG&A year-on-year change?
- What is Pfizer TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Pfizer?
- What is Pfizer TTM SG&A year-on-year change?
What is Pfizer annual selling, general & administrative expenses?
The current annual SG&A of PFE is $14.77 B
What is the all time high annual SG&A for Pfizer?
Pfizer all-time high annual selling, general & administrative expenses is $18.97 B
What is Pfizer annual SG&A year-on-year change?
Over the past year, PFE annual selling, general & administrative expenses has changed by +$1.09 B (+8.00%)
What is Pfizer quarterly selling, general & administrative expenses?
The current quarterly SG&A of PFE is $3.24 B
What is the all time high quarterly SG&A for Pfizer?
Pfizer all-time high quarterly selling, general & administrative expenses is $5.67 B
What is Pfizer quarterly SG&A year-on-year change?
Over the past year, PFE quarterly selling, general & administrative expenses has changed by -$37.00 M (-1.13%)
What is Pfizer TTM selling, general & administrative expenses?
The current TTM SG&A of PFE is $477.33 B
What is the all time high TTM SG&A for Pfizer?
Pfizer all-time high TTM selling, general & administrative expenses is $19.14 B
What is Pfizer TTM SG&A year-on-year change?
Over the past year, PFE TTM selling, general & administrative expenses has changed by +$462.49 B (+3116.27%)